Dr. Mohita Shrivastava is an internationally trained neuroscientist and neuropsychologist with extensive expertise in cognitive health, neuroimaging, and neurotherapeutics. She holds a Ph.D. in Neurosciences from the Neurosciences Centre, AIIMS (New Delhi, India), with research training at the University of Kansas Medical Center (USA). Additionally, she earned two masters degreesone in Biomedical Sciences (University of Delhi) and another in Applied Clinical Psychology (Annamalai University)-along with an Advanced PG Diploma in Applied Neuropsychology (University of Bristol, UK). Her specialized training includes: Refresher course on fMRI in Neuroscience Research (MGH Martinos Center, USA); EEG/QEEG (Successful Practitioner & InMindOut, USA , & STS Inc., USA in the process of certification from the International QEEG Board; QEEG & Neurofeedback practicum training with Successful Practitioner & InMindOut, USA. As the Founder & CEO of the Cognitome Program, Dr. Shrivastava leads a pioneering neuroscientific initiative. The Cognitome Program that addresses cognitive impairment, age-related cognitive decline, and cognitive-behavioral health through evidence-based interventions leveraging neuroplasticity and neuroscientific mindfulness based pactice. Dr. Shrivastava serves on editorial boards for leading neuroscience journals and is an active member of international neuroscience societies, driving innovation in brain health research and therapy. She has published multiple research, review and magazine articles, in internationally acclaimed peer-reviewed neuroscience journals, and contributed columns on mental health for Khaleej Times (UAE), WKND Magazine, and Passion Vista Global Magazine. She has also been featured in MedEdge MEA magazine(2024) and Passion Vistas Global Magazine Hall of Fame Edition (2023).